AJP - Heart AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 296: H862-H867, 2009. First published January 23, 2009; doi:10.1152/ajpheart.01141.2008
0363-6135/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/3/H862    most recent
01141.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kiessling, J. W.
Right arrow Articles by Armstead, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kiessling, J. W.
Right arrow Articles by Armstead, W. M.

Inhibition of integrin {alpha}Vβ3 prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia

J. Willis Kiessling,1 Douglas B. Cines,2 Abd Al-Roof Higazi,2,3 and William M. Armstead1

Departments of 1Anesthesiology and Critical Care and Pharmacology and 2Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and 3Department of Clinical Biochemistry, Hebrew University-Hadassah Medical School, Jerusalem, Israel

Submitted 29 October 2008 ; accepted in final form 20 January 2009

Cerebral hypoxia (10 min) followed immediately by ischemia (20 min) (H/I) impairs cerebrovasodilation in response to hypercapnia and hypotension in the newborn pig; exogenous urokinase plasminogen activator (uPA) potentiates this effect, whereas the blockade of endogenous uPA-mediated vasoactivity prevents it completely. This study investigated the role of integrin {alpha}Vβ3 in the uPA-mediated impairment of cerebrovasodilation after H/I in piglets equipped with a closed cranial window. Pial artery dilation induced by hypercapnia (PCO2, 75 mmHg) and hypotension (mean arterial blood pressure, decreased by 45%) was blunted after H/I, reversed to vasconstriction in piglets treated with uPA (10–7 M), a concentration observed in cerebrospinal fluid after H/I, but reverted to a dilation no different than preinsult in piglets administered an anti-{alpha}Vβ3 antibody (10 ng/ml) in addition to uPA (26 ± 1, 9 ± 1, –10 ± 3, and 22 ± 3% for hypercapnia before H/I, after H/I, after H/I with uPA, and after H/I with combined uPA and anti-{alpha}Vβ3 antibody, respectively). Responses to isoproterenol were unchanged after H/I and combined uPA and anti-{alpha}Vβ3 antibody. Similar results were obtained for the combined administration of uPA with the {alpha}Vβ3 antagonist Arg-Gly-Asp-D-Phe-Val and Arg-Gly-Asp-Ser, but not for the inactive analog Arg-Gly-Asp-Glu-Ser acetate. These data show that the activation of the integrin {alpha}Vβ3 contributes to the uPA-mediated impairment of pial artery dilation after H/I. These data suggest that the inhibition of uPA and integrin signaling may preserve cerebrohemodynamic control after H/I.

cerebral circulation; newborn; signal transduction



Address for reprint requests and other correspondence: W. M. Armstead, Dept. of Anesthesiology and Critical Care, 3620 Hamilton Walk, JM3, Univ. of Pennsylvania, Philadelphia, PA l9l04 (e-mail: armsteaw{at}uphs.upenn.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.